Evaluation of neurobehavioral and neuroinflammatory end-points in the post-exposure period in rats sub-acutely exposed to manganese

Santos Dinamene, Batoreu M. Camila, I. Tavares de Almeida, L. Davis Randall, Mateus M. Luisa, Andrade Vanda, Ramos Ruben, Torres Edite, Michael Aschner, A. P. Marreilha dos Santos

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Manganese (Mn) can cause manganism, a neurological disorder similar to Parkinson' Disease (PD). The neurobehavioral and neuroinflammatory end-points in the Mn post exposure period have not been studied yet. Rats were injected on alternate days with 8 doses of MnCl2 (25mg/kg) or saline, then euthanized 1, 10, 30 or 70 days following the last dose. Whole-blood (WB) (p<0.05), urine (p<0.05) and brain cortical (p<0.0001) Mn levels were significantly increased 24h after the last dose. Decreases in the rats' ambulation were noted 1, 10 and 30 days after the last Mn dose (p<0.001; p<0.05; p<0.001, respectively) and also in the rearing activity at the four time-points (p<0.05). Cortical glial fibrillary acid protein immunoreactivity (GFAP-ir) was significantly increased at 1, 10, 30 (p<0.0001) and 70 (p<0.001) days after the last Mn dose, as well as tumor necrosis α (TNF-α) levels (p<0.05) but just on day 1. Taken together, the results show that, during the 70-day clearance phase of Mn, the recovery is not immediate as behavioral alterations and neuroinflammation persist long after Mn is cleared from the cortical brain compartment.

Original languageEnglish (US)
Pages (from-to)95-99
Number of pages5
JournalToxicology
Volume314
Issue number1
DOIs
StatePublished - Dec 6 2013
Externally publishedYes

Fingerprint

Manganese
Rats
Brain
Glial Fibrillary Acidic Protein
Nervous System Diseases
Walking
Parkinson Disease
Tumors
Blood
Necrosis
Urine
Recovery
Neoplasms

Keywords

  • GFAP
  • Manganese neurotoxicity
  • Neurobehavioral assays
  • Neuroinflammation
  • TNF-α

ASJC Scopus subject areas

  • Toxicology
  • Medicine(all)

Cite this

Dinamene, S., Camila, B. M., Tavares de Almeida, I., Davis Randall, L., Luisa, M. M., Vanda, A., ... Marreilha dos Santos, A. P. (2013). Evaluation of neurobehavioral and neuroinflammatory end-points in the post-exposure period in rats sub-acutely exposed to manganese. Toxicology, 314(1), 95-99. https://doi.org/10.1016/j.tox.2013.09.008

Evaluation of neurobehavioral and neuroinflammatory end-points in the post-exposure period in rats sub-acutely exposed to manganese. / Dinamene, Santos; Camila, Batoreu M.; Tavares de Almeida, I.; Davis Randall, L.; Luisa, Mateus M.; Vanda, Andrade; Ruben, Ramos; Edite, Torres; Aschner, Michael; Marreilha dos Santos, A. P.

In: Toxicology, Vol. 314, No. 1, 06.12.2013, p. 95-99.

Research output: Contribution to journalArticle

Dinamene, S, Camila, BM, Tavares de Almeida, I, Davis Randall, L, Luisa, MM, Vanda, A, Ruben, R, Edite, T, Aschner, M & Marreilha dos Santos, AP 2013, 'Evaluation of neurobehavioral and neuroinflammatory end-points in the post-exposure period in rats sub-acutely exposed to manganese', Toxicology, vol. 314, no. 1, pp. 95-99. https://doi.org/10.1016/j.tox.2013.09.008
Dinamene, Santos ; Camila, Batoreu M. ; Tavares de Almeida, I. ; Davis Randall, L. ; Luisa, Mateus M. ; Vanda, Andrade ; Ruben, Ramos ; Edite, Torres ; Aschner, Michael ; Marreilha dos Santos, A. P. / Evaluation of neurobehavioral and neuroinflammatory end-points in the post-exposure period in rats sub-acutely exposed to manganese. In: Toxicology. 2013 ; Vol. 314, No. 1. pp. 95-99.
@article{7f33fee29ed74c568c84b8eb0fac7f89,
title = "Evaluation of neurobehavioral and neuroinflammatory end-points in the post-exposure period in rats sub-acutely exposed to manganese",
abstract = "Manganese (Mn) can cause manganism, a neurological disorder similar to Parkinson' Disease (PD). The neurobehavioral and neuroinflammatory end-points in the Mn post exposure period have not been studied yet. Rats were injected on alternate days with 8 doses of MnCl2 (25mg/kg) or saline, then euthanized 1, 10, 30 or 70 days following the last dose. Whole-blood (WB) (p<0.05), urine (p<0.05) and brain cortical (p<0.0001) Mn levels were significantly increased 24h after the last dose. Decreases in the rats' ambulation were noted 1, 10 and 30 days after the last Mn dose (p<0.001; p<0.05; p<0.001, respectively) and also in the rearing activity at the four time-points (p<0.05). Cortical glial fibrillary acid protein immunoreactivity (GFAP-ir) was significantly increased at 1, 10, 30 (p<0.0001) and 70 (p<0.001) days after the last Mn dose, as well as tumor necrosis α (TNF-α) levels (p<0.05) but just on day 1. Taken together, the results show that, during the 70-day clearance phase of Mn, the recovery is not immediate as behavioral alterations and neuroinflammation persist long after Mn is cleared from the cortical brain compartment.",
keywords = "GFAP, Manganese neurotoxicity, Neurobehavioral assays, Neuroinflammation, TNF-α",
author = "Santos Dinamene and Camila, {Batoreu M.} and {Tavares de Almeida}, I. and {Davis Randall}, L. and Luisa, {Mateus M.} and Andrade Vanda and Ramos Ruben and Torres Edite and Michael Aschner and {Marreilha dos Santos}, {A. P.}",
year = "2013",
month = "12",
day = "6",
doi = "10.1016/j.tox.2013.09.008",
language = "English (US)",
volume = "314",
pages = "95--99",
journal = "Toxicology",
issn = "0300-483X",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Evaluation of neurobehavioral and neuroinflammatory end-points in the post-exposure period in rats sub-acutely exposed to manganese

AU - Dinamene, Santos

AU - Camila, Batoreu M.

AU - Tavares de Almeida, I.

AU - Davis Randall, L.

AU - Luisa, Mateus M.

AU - Vanda, Andrade

AU - Ruben, Ramos

AU - Edite, Torres

AU - Aschner, Michael

AU - Marreilha dos Santos, A. P.

PY - 2013/12/6

Y1 - 2013/12/6

N2 - Manganese (Mn) can cause manganism, a neurological disorder similar to Parkinson' Disease (PD). The neurobehavioral and neuroinflammatory end-points in the Mn post exposure period have not been studied yet. Rats were injected on alternate days with 8 doses of MnCl2 (25mg/kg) or saline, then euthanized 1, 10, 30 or 70 days following the last dose. Whole-blood (WB) (p<0.05), urine (p<0.05) and brain cortical (p<0.0001) Mn levels were significantly increased 24h after the last dose. Decreases in the rats' ambulation were noted 1, 10 and 30 days after the last Mn dose (p<0.001; p<0.05; p<0.001, respectively) and also in the rearing activity at the four time-points (p<0.05). Cortical glial fibrillary acid protein immunoreactivity (GFAP-ir) was significantly increased at 1, 10, 30 (p<0.0001) and 70 (p<0.001) days after the last Mn dose, as well as tumor necrosis α (TNF-α) levels (p<0.05) but just on day 1. Taken together, the results show that, during the 70-day clearance phase of Mn, the recovery is not immediate as behavioral alterations and neuroinflammation persist long after Mn is cleared from the cortical brain compartment.

AB - Manganese (Mn) can cause manganism, a neurological disorder similar to Parkinson' Disease (PD). The neurobehavioral and neuroinflammatory end-points in the Mn post exposure period have not been studied yet. Rats were injected on alternate days with 8 doses of MnCl2 (25mg/kg) or saline, then euthanized 1, 10, 30 or 70 days following the last dose. Whole-blood (WB) (p<0.05), urine (p<0.05) and brain cortical (p<0.0001) Mn levels were significantly increased 24h after the last dose. Decreases in the rats' ambulation were noted 1, 10 and 30 days after the last Mn dose (p<0.001; p<0.05; p<0.001, respectively) and also in the rearing activity at the four time-points (p<0.05). Cortical glial fibrillary acid protein immunoreactivity (GFAP-ir) was significantly increased at 1, 10, 30 (p<0.0001) and 70 (p<0.001) days after the last Mn dose, as well as tumor necrosis α (TNF-α) levels (p<0.05) but just on day 1. Taken together, the results show that, during the 70-day clearance phase of Mn, the recovery is not immediate as behavioral alterations and neuroinflammation persist long after Mn is cleared from the cortical brain compartment.

KW - GFAP

KW - Manganese neurotoxicity

KW - Neurobehavioral assays

KW - Neuroinflammation

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=84885808335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885808335&partnerID=8YFLogxK

U2 - 10.1016/j.tox.2013.09.008

DO - 10.1016/j.tox.2013.09.008

M3 - Article

VL - 314

SP - 95

EP - 99

JO - Toxicology

JF - Toxicology

SN - 0300-483X

IS - 1

ER -